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Abstract 
Loneliness and social isolation are associated with depression, anxiety and a progressive loss of higher cognitive 
faculties, mainly in older adults.  In the current pandemic situation, with serious restrictions that limit interactions with 
members of our social circles, these cognitive alterations are becoming progressively more obvious in young adults, 
adolescents and even children.  With the addition of eating disorders, sleep disturbances, and lack of exposure to solar 
radiation due to confinement, the condition can be considerably worse.  Fortunately, there are two allies which from a 
psychological point of view, have many common features and could help to reverse some of the effects of social isolation; 
these molecules are melatonin and vitamin D.  Their complementary functions on circadian rhythmicity may be useful in 
reestablishing mood balance.  Thus, we suggest a re-education in new hygienic-dietary habits, especially related to the 
maintenance of adequate levels of melatonin and vitamin D, which may help prevent and possibly reverse the cognitive 
and psychological disorders until social contact is reestablished. 
 




1.  Introduction  
1.1  Social isolation affects cognitive faculties, or 
is it the other way around? 
Social connections are known to be vital 
to survival throughout the animal kingdom and 
are dynamic throughout life.  The consequences 
of social isolation and loneliness are increasingly 
a primary consideration in health care, disease 
prevention, and the degree of success in recovery 
processes (Matthews & Tye, 2019).  One of the 
main consequences of confinement is the decline 
in cognitive faculties (Evans et al., 2019; Mengin 
et al., 2020).  An example of this is being observed 
in the recent pandemic caused by the SARS-CoV-
2 virus, where the elderly are the first affected 
(Chu, Donato-Woodger, & Dainton, 2020).  These 
sequelae arise both from the effects of social 
isolation (Chu et al., 2020; Su et al., 2020) and, 
secondly, the emotional disturbance associated 
with the experience of going through intensive 
therapy (Jaffri & Jaffri 2020).  Everything seems 
to go in the opposite direction under these 
circumstances thereby emphasizing how 
important it is to maintain a socially active 
lifestyle (Malone, Liu, Vaillant, Rentz, & 
Waldinger, 2015; Röhr et al., 2020). 
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Although no psychological disorders 
were observed in the first weeks of isolation in 
countries such as China and Italy, when social 
restriction was several weeks long, disorders in 
various cognitive faculties became apparent (Su et 
al., 2020).  Undoubtedly, these disorders were 
associated with reduced social interactions in 
young adults and adolescents and even in 
children.  These included anxiety, post-traumatic 
stress disorder, depression, suicidal or addictive 
behaviors, domestic violence, eating, and sleeping 
disorders (Lopes & Jaspal, 2020; Ma et al., 2020; 
Mengin et al., 2020).  Additionally, there are 
various problems of abuse of different drugs such 
as benzodiazepines or prescription opioids, 
without considering the cases of self-medication 
in single older adults in a situation of social 
isolation (Day & Rosenthal, 2020).  The long 
duration of social confinement usually caused the 
psyche to undergo those changes (Su et al., 2020).  
While it is still too early to determine 
whether a prolonged duration of social 
confinement that usually causes the psyche to 
undergo these changes will be associated with 
changes at the neuronal level, the scientific 
evidence shows -for example, in pathologies that 
present symptoms of isolation or of affective 
flattening such as autism- a correlation with a 
reduction in the activity of neurons in specific 
areas as well as a decrease in the volume of certain 
brain nuclei (Hoogman et al., 2020).  Cognitive-
behavioral therapy is commonly used in these 
cases, but there are new alternatives that science 
shows could help the recovery of these patients.  
One of the alternatives that may be useful from a 
more immediate point of view is augmented 
reality technologies such as a virtual group bike 
ride.  This practice is carried out in residential 
centers for the elderly and has brought many 
benefits that counteract the effects of social 
isolation (Appel et al., 2020; D’Cunha et al., 
2020).  Other alternatives with some limited 
results are animal therapy, new skills, social 
services, and others (Freedman & Nicolle 2020). 
New treatments with a more molecular 
focus are currently being tested to control 
behavioral alterations, for example, in the 
regulation of genes responsible for epigenetic 
modulation using proven drugs.  These immediate 
early genes (IEG) are known to play an essential 
role in neuronal plasticity, memory, and behavior 
(Maes et al., 2020).  For instance, vafidemstat 
(ORY-2001) in phase IIa trials appears to be 
capable of controlling some of these IEGs, correct 
memory deficits, ameliorate behavioral 
disturbances, and reduce neuroinflammatory 
processes (Maes et al., 2020).  Perhaps this kind 
of drugs could soon be used to reduce the possible 
consequences of the social isolation we face 
today. 
As a potential treatment for future 
emotional disorders that this pandemic may leave, 
attention could be directed at drugs that may 
influence the activity of the enzyme glycogen 
synthase 3β (GSK3β).  The activity of this agent 
on dopaminergic systems of the medial prefrontal 
cortex is intimately involved in controlling higher 
cognitive functions (Bramson et al., 2020; 
Khlghatyan & Beaulieu, 2020; Li et al., 2020).  
The results of a study in knockout mice to silence 
the RNA of the enzyme demonstrated the 
participation of GSK3β in the regulation of 
behaviors related to mood and emotions 
(Khlghatyan & Beaulieu, 2020). 
Not only do concerns for the mental 
health of the population come from the effects of 
social isolation, but at the other extreme, those 
patients who have been infected by the SARS-
CoV-2 virus and admitted to intensive care units 
and who manage to recover suffer from so-called 
post-intensive care syndrome (PICS) (Jaffri & 
Jaffri 2020). PICS, is characterized by physical 
disability, mental health problems, and cognitive 
impairment that require a multidisciplinary 
treatment team (Klok et al., 2020; Smith et al., 
2020).  Clearly, prevention and treatment of brain 
disorders not only should be made in those 
patients with cognitive deterioration caused by 
social isolation but also in those patients who have 
managed to overcome the SARS-CoV-2 infection, 
focusing mainly on the elderly (Chu et al., 2020; 
Ma et al., 2020).  
To help prevent these loss-of-contact 
disorders, stimulating and developing a resilient 
attitude would be helpful.  Resilience has become 
something of vital importance to better cope with 
the situation that the world population is currently 
experiencing (Vinkers et al., 2020).  Moreover, 
this process may be accompanied by the 
regulation of certain habits that have been 
misdirected in this pandemic.  One of the most 
common bad habits is poor regulation of the sleep 
cycle due to stress, i.e., chronodisruption; which 
contributes with the cognitive disturbances. 
GARCÍA MENÉNDEZ ET AL 
JCST Vol. 11 No. 1 Jan.-Apr. 2021, pp. 158-170 
160 
 
2.  Could melatonin help in alleviating 
cognitive disorders?  
Traumatic situations, whether related to 
personal life or caused by natural disasters, act by 
directly altering sleep regulation.  During the 
current pandemic, many individuals have altered 
the timing of their daily routine, among many 
other perturbations (Cellini, Canale, Mioni, & 
Costa, 2020).  Circadian disruption 
(chronodisruption) occurs when regular routines 
and internal rhythms are changed relative to the 
light:dark environment such that they are 
temporally desynchronized.  These changes may 
induce alterations in body homeostasis, ranging 
from changes in cognitive abilities, behavior and 
performance (Rodrigues, Marques, & Gomes, 
2019) to metabolic disorders (Cipolla-Neto, 
Amaral, Afeche, Tan, & Reiter, 2014; Rumanova, 
Okuliarova, & Zeman, 2020).  The current social 
isolation caused by the pandemic may act as a 
catalyst for the disruption of the circadian 
rhythms.  Thus, specialists in chronobiology have 
focused on this phenomenon (Erren & Lewis, 
2020).   
Melatonin is a ubiquitous ancestral 
molecule that has multiple functions in practically 
all living organisms.  Of relevance to the current 
situation, the circadian secretion of pineal gland 
and possibly the synthesis of extrapineal 
melatonin (Acuña-Castroviejo et al., 2017) 
function as a chronobiotic, thus playing an 
essential role in the regulation of the circadian 
temporal internal order (Rodriguez et al., 2019; 
Cipolla-Neto et al., 2014). 
The perturbed body homeostasis and 
allostatic load due to poor sleep hygiene have 
direct impacts at the cellular level (Egg et al., 
2014; Acuña-Castroviejo et al., 2017; Bellanti et 
al., 2017; Ali et al., 2020; Mocayar Marón, Ferder, 
Reiter, & Manucha, 2020; Verma, Singh, & Rizvi, 
2020) and the latter translate into a higher 
probability of developing pathologies ranging 
from metabolic disorders, cardiovascular 
diseases, immune system disorders, infertility, 
neurodegenerative deterioration and cancer (Al-
Sarraf, Kasabri, Akour, & Naffa, 2018; Erren, 
Morfeld, Groß, Wild, & Lewis, 2019; Du & 
Holme, 2020; García Martín Giménez, Mocayar 
Marón, Reiter, & Manucha, 2020; Lateef & 
Akintubosun, 2020; Morton et al., 2020; 
Schilperoort et al., 2020).  The beneficial effects 
of melatonin would likely help to alleviate the 
disrupted circadian biology associated with the 
ongoing pandemic, which would be in addition to 
its evident antiviral actions (Feitosa et al., 2020) 
and could well be an effective antidote to the 
psychological consequences that social isolation 
is causing (Erren & Lewis, 2020; Mengin et al., 
2020).  While the benefits of its administration in 
animal models have been known for decades (Nie 
et al., 2017; Bano-Otalora, Madrid, & Rol, 2019; 
Jürgenson et al., 2019; Verma et al., 2020), the use 
of this molecule is increasingly being extended in 
various treatment schemes in humans (Agorastos 
& Linthorst, 2016; Xiao et al., 2019; Erren & 
Lewis, 2020; Galindo Muñoz et al., 2020; Latif 
Khan et al., 2020).  Since the antioxidant, anti-
inflammatory, and immunomodulatory properties 
of this molecule are well known, recently the 
scientific community has proposed it as a 
potential treatment against COVID-19 (Martín 
Giménez et al., 2020; Shneider, Kudriavtsev, & 
Vakhrusheva, 2020; Zhang et al., 2020).  Beyond 
its ability to counteract the virus, its chronobiotic 
activity would likely be beneficial during the 
period of social isolation. 
The promising dual effect of melatonin 
could also help with another primary concern in 
the healthcare community: gestational 
chronodisruption (Zhang et al., 2020).  Maternal 
circadian rhythms provide essential circadian 
information to the fetal biological clock for 
synchronization and programming (Salazar et al., 
2018).  The recent pandemic caused by SARS-
CoV-2 has forced alterations to social habits and, 
with it, the duration of exposure to natural light.  
This may have unfavorable consequences for 
pregnant women and their fetuses (Bagci, Sabir, 
Müller, & Reiter, 2020).  Thus, while melatonin 
may help to overcome the psychological effects of 
the social isolation in the present generation, it 
may also be of benefit for the optimal health of 
next generation (Zhang et al., 2020).  Of special 
interest, this chronobiotic may be assisted by 
another important molecule, vitamin D, in 
overcoming the negative effects of social isolation 
(Martín Giménez et al., 2020). 
 
3.  Could vitamin D help in alleviating 
cognitive disorders? 
Low vitamin D levels and poor sleep 
quality are associated with the development of 
cognitive dysfunction in healthy people (Song & 
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Wu, 2018).  Hypovitaminosis D is a condition that 
increases the risk of developing cognitive 
impairment and dementia, especially in older 
people (Annweiler et al., 2015).  Vitamin D 
deficiency is usually linked to a reduction in the 
volume of several hippocampal subfields and 
disrupted connections in hippocampal network of 
older people with mild cognitive impairment; 
which may worsen neurocognitive disease 
prognosis in these patients (Al-Amin et al., 2019).  
Below normal vitamin D levels are also 
associated with an increase in the severity of 
negative symptoms in patients with schizophrenia 
(Graham et al., 2015).  Moreover, a vitamin D 
deficiency is also related to neuronal integrity 
disruption, particularly in frontal brain regions, 
and may lead to the reduction of neuroprotection 
during cerebral ischemia, contributing to memory 
loss and other permanent deficits (Moon, Moon, 
Kwon, Lee, & Han, 2015).  As another example, 
autistic children are more frequently deficient in 
vitamin D than are non-autistic children, which 
may exacerbate this psychiatric pathology (Guo et 
al., 2019). 
Of particular interest, vitamin D 
supplementation attenuates the cognitive 
impairment observed in diabetic animals, possibly 
through the enhancement in cholinergic 
transmission at the prefrontal cortex level 
(Alrefaie & Alhayani, 2015).  Vitamin D also 
reduces irritability and hyperactivity symptoms in 
children with autism spectrum disorder 
(Mazahery et al., 2019).  Even in stroke patients, 
high vitamin D levels are associated with less 
cognitive impairment (Yalbuzdag et al., 2015).  
To highlight, vitamin D deficiency 
impairs the synthesis and release of serotonin.  
This neurotransmitter is responsible for the 
maintenance of multiple cognitive processes and 
brain functions related to mood.  Therefore, 
serotonin dysfunction would lead to the 
exacerbation of neuropsychiatric disorders such 
as depression, among other associated alterations 
(Patrick & Ames, 2015). Suicidally-depressed 
individuals show significantly reduced vitamin D 
levels compared to depressed people who are not 
suicidal.  Thus, the more exaggerated the vitamin 
D deficiency, the greater the manifested 
depressive symptoms (Jo, Zhang, Emrich, & 
Dietrich, 2015).  In young girls with severe 
hypovitaminosis D, vitamin D supplementation 
caused a reduction in the intensity of mood 
disorders associated with premenstrual syndrome.  
Some of these mood disorders included anxiety, 
irritability, sadness, and disturbed relationships 
(Tartagni et al., 2016).  Severe vitamin D 
deficiency could also be responsible for 
developing psychiatric eating disorders such as 
bulimia nervosa and anorexia nervosa (Tasegian 
et al., 2016). Hypovitaminosis D may also be 
associated with greater anxiety levels, 
contributing to the increased future risk of 
psychosis (Kelley, Sanders, & Beaton, 2016; 
Bičíková et al., 2015).  One study reported that 
mice with vitamin D deficiency showed greater 
vulnerability to the psychiatric effects of social 
stress (Groves, Zhou, Jhaveri, McGrath, & Burne, 
2017).  Vitamin D deficiency is also related to the 
development of agoraphobia, an anxiety disorder 
characterized by an irrational fear of entering 
open or crowded places, leaving one's own home, 
or being in places where escape is perceived to be 
difficult (Fond et al., 2019).  Low vitamin D 
serum levels are often in patients with stroke and 
mood disorders.  Likewise, hypovitaminosis D 
could increase the risk of developing depression 
in post-stroke individuals (Wu et al., 2016).  
Moreover, a potential relationship between 
vitamin D status and the probability of developing 
antenatal depression and/or postpartum 
depression has been suggested (Aghajafari, 
Letourneau, Mahinpey, Cosic, & Giesbrecht, 
2018).  Finally, it has been observed that the 
behavior, emotion, and attention of children may 
be negatively affected by a vitamin D deficiency 
(Wang et al., 2020). 
Vitamin D supplementation may 
significantly reduce negative emotions (Cheng, 
Huang, & Huang, 2020). It has been found to 
reduce psychological sequelae (stress, depression, 
and anxiety) observed in patients surviving 
natural disasters such as floods or earthquakes 
(Kaplan, Rucklidge, Romijn, & Dolph, 2015).  
One study also demonstrated that vitamin D has 
strong anxiolytic-like effects in an experimental 
rat model of long-term estrogen deficiency 
induced by ovariectomy (Fedotova, Pivina, & 
Sushko, 2017; Fedotova et al., 2017).  Of 
additional interest is one report which indicated 
that skin exposure to ultraviolet radiation 
improved circulating vitamin D levels and mood, 
especially in those who prefer the evening for 
performing their daily activities (Toledo et al., 
2019). 
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From the analysis of the evidence 
summarized above, it is clear that vitamin D 
deficiency may induce brain disorders in 
previously healthy people under conditions that 
predispose them to psychological changes and 
may worsen or exacerbate the status or 
progression of existing psychiatric pathologies.  
In any case, vitamin D supplementation could 
prevent mood disorders that may develop or 
worsen during the COVID-19 pandemic (Patrick 
& Ames, 2015), especially considering that 
quarantine and imposed isolation to indoor places 
reduce sunlight exposure, which is important for 
the endogenous synthesis of vitamin D (Nair & 
Maseeh, 2012).  
 
4.  Conclusions and prospects 
Herein, with the current pandemic 
situation we propose a feedback loop that 
increases the likelihood of developing 
psychological impairments due to deficits in 
circadian organization (which can be minimized 
by regular melatonin use) and a relative vitamin D 
deficiency (Figure 1).  SARS-CoV-2, a highly 
infectious virus, has forced social isolation to 
flatten the contagion curve.  While this measure 
has provided protection against the spread of the 
virus, it is also generating parallel mental health 
problems that should not be ignored.  One of the 
main consequences of social isolation is that it 
mainly generates stress, anxiety, and depression 
(Lopes & Jaspal, 2020; Ma et al., 2020, Mengin et 
al., 2020).  This emotional change adds to changes 
in exposure to sunlight, and consequently, 
alterations in sleep cycles cause by 
chronodisruption that directly affects metabolic 
and psychiatric homeostasis (Erren & Lewis, 
2020).  In turn, this leads, among other things, to 
a dysregulation of the immune system and 
contributes to an increased vulnerability to the 























Figure 1.  This cycle describes an interrelation between external and internal factors that increase the possibility of 
contagion with the COVID-19 virus.  
Analyzing this from a graphic 
perspective, some behavioral adjustment may 
help to break this negative cycle (Figure 2).  One 
of them involves changing underlying circadian 
rhythms using a treatment scheme with melatonin 
and vitamin D (Martín Giménez et al., 2020).  
Another means to overcome the endogenous 
disruption arising from isolation is replacing bad 
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habits with healthier ones under these unfamiliar 
conditions.  As examples, mobile phone, tablet, 
computer, and TV use should be avoided where 
possible for at least 2 hours before sleep time.  
Blue light emitted by these screens maximally 
inhibits natural melatonin production at night 
(Wahl, Engelhardt, Schaupp, Lappe, & Ivanov, 
2019).  Daytime activities could also be adjusted 
since both low and excessive daily activities 
negatively affect sleep quality (Gulia & Kumar, 
2020).  Performing daytime activities under 
natural light, aids not only in helping to correct 
circadian rhythms, but also in promoting the 
endogenous synthesis of vitamin D, a molecule 
that is highly beneficial (Patrick & Ames, 2015).  
Whether converting to healthier habits or by using 
exogenous treatments to adjust rhythms and 
metabolism, supplemental melatonin and vitamin 


























Figure 2.  
Representation of the breaking points of the COVID-19 virus contagion cycle (green arrows).  The stimulating (blue 
fringes) or inhibitory (red dashed lines) actions of vitamin D and melatonin act synergistically on critical points in the 
cycle.  The increases in the endogenous levels of these molecules can be achieved physiologically through changes in 
some habits, as well as through the external administration of these drugs. 
 
This pandemic has tested our resilience 
in every respect.  Consequently, to cope with 
current and future behavioral problems associated 
with social isolation, it is important to  
use current scientific knowledge to benefit 
individual and community health.  This strategy 
will enhance the possibility of avoiding lingering 
mental effects of this extreme situation.  
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